I am pleased to announce the establishment of a new WuXi business division, the Research Service Division (RSD), aimed at providing better support to our partners and promoting efficiency and collaboration between WuXi’s business units. RSD combines WuXi’s capability and technology platform in chemistry and biology to provide open access and integrated service for drug discovery and research. The services included in the new RSD are the International Discovery Service Unit (IDSU), Chemistry Service Unit (CSU), Oncology Unit, the Immunology Center, and Biology Unit (which includes HTS, in vitro screening, infectious disease, neurosciences, CV, and metabolism). This new integration will provide closer points of contacts for our partners and discovery teams, streamline the exceptional services offered across our platform, and enhance efficiency and productivity to drug discovery. We will focus on boosting our scientific capabilities and leading technology development to maintain WuXi’s industry leading position in research service. I look forward to continuing to provide outstanding service to our partners through this new initiative and connecting to our broader discovery community through the new RSDpress!